Häring H, Obermaier B, Ermel B, Su Z, Mushack J, Rattenhuber E, Hölzl J, Kirsch D, Machicao F, Herberg L
Institut für Diabetesforschung, München.
Diabete Metab. 1987 Jul;13(3 Pt 2):284-93.
The insulin receptor contains in its beta-subunit a tyrosine (-) specific protein kinase. It is believed that transmission of an insulin signal across the plasma membrane of target cells of insulin action occurs through activation of this kinase, autophosphorylation of the insulin receptor beta-subunit and subsequent phosphorylation of other cellular substrates. We studied the insulin receptor kinase in a number of insulin resistant cell systems in order to elucidate if defects of this kinase are a possible cause of cellular insulin resistance. Three different patterns of kinase abnormalities were found, in different insulin resistant cells: 1. In an insulin resistance melanoma cell line a reduced receptor kinase autophosphorylation was found apparently due to a defect of the tyrosine autophosphorylation sites of this receptor; 2. Catecholamine and phorbol ester induced insulin resistance of isolated rat fat cells as well as human fat cells was associated with a decreased activity of the insulin receptor tyrosine kinase which was apparently due to a modulation of the ATP binding site of the insulin receptor tyrosine kinase; 3. The receptor kinase isolated from the skeletal muscle of diabetic Zucker rats (fa/fa) was found to be insulin insensitive with no major alteration of maximal responsiveness. These results suggested that different forms of kinase defects exist which can contribute to the pathogenesis of cellular insulin resistance. Based on these data studies in skeletal muscle from type II diabetic patients were started. Results from five patients so far suggest that, here as well, an abnormality of the insulin receptor kinase exists which might be involved in the pathogenesis of insulin resistance in type II diabetes.
胰岛素受体的β亚基含有一种酪氨酸特异性蛋白激酶。据信,胰岛素信号通过该激酶的激活、胰岛素受体β亚基的自身磷酸化以及随后其他细胞底物的磷酸化,穿过胰岛素作用靶细胞的质膜进行传递。我们在一些胰岛素抵抗细胞系统中研究了胰岛素受体激酶,以阐明该激酶的缺陷是否可能是细胞胰岛素抵抗的原因。在不同的胰岛素抵抗细胞中发现了三种不同类型的激酶异常:1. 在一种胰岛素抵抗性黑色素瘤细胞系中,发现受体激酶自身磷酸化减少,显然是由于该受体酪氨酸自身磷酸化位点存在缺陷;2. 儿茶酚胺和佛波酯诱导的大鼠分离脂肪细胞以及人脂肪细胞的胰岛素抵抗与胰岛素受体酪氨酸激酶活性降低有关,这显然是由于胰岛素受体酪氨酸激酶的ATP结合位点受到调节;3. 从糖尿病Zucker大鼠(fa/fa)骨骼肌中分离出的受体激酶对胰岛素不敏感,最大反应性无明显改变。这些结果表明,存在不同形式的激酶缺陷,它们可能参与细胞胰岛素抵抗的发病机制。基于这些数据,我们开始了对II型糖尿病患者骨骼肌的研究。到目前为止,来自五名患者的结果表明,这里也存在胰岛素受体激酶异常,这可能与II型糖尿病胰岛素抵抗的发病机制有关。